Financials in USD. Standardized financial statements.
A compact view of how Generex Biotechnology Corporation turns revenue into operating income and net income.
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.66M | $6.20M | $703,244 | $0 | $0 | $0 | $0 | $0 | $28,651 | $291,628 |
| Revenue Growth? | -57.1% | +782.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | -90.2% | 0.0% |
| Cost of Revenue? | $579,857 | $4.14M | $0 | $0 | $0 | $0 | $0 | $0 | $11,109 | $155,619 |
| Gross Profit? | $2.08M | $2.06M | $703,244 | $0 | $0 | $0 | $0 | $0 | $17,542 | $136,009 |
| Gross Margin? | +78.2% | +33.3% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +61.2% | +46.6% |
| Operating Expenses? | $19.82M | $23.16M | $3.20M | $1.60M | $1.90M | $3.88M | $4.40M | $6.13M | $10.04M | $24.67M |
| Operating Income? | -$17.92M | -$21.09B | -$2.50M | -$1.60M | -$1.90M | -$3.88M | -$4.40M | -$6.13M | -$10.02B | -$24.53M |
| EBITDA? | -$26.11M | -$21.07B | $36.94M | -$69.27M | -$2.54M | -$1.46M | $688,700 | -$7.56M | -$8.29M | -$20.72M |
| Income Before Tax | -$34.23M | -$11.01M | $35.95M | -$76.83M | -$3.22M | -$2.19M | -$1,417 | -$8.55M | -$9.49B | -$21.68B |
| Income Tax Expense | -$9.19M | $20.43M | $39.03M | -$74.49M | $0 | $0 | $4.72M | $0 | $1.72M | $3.27M |
| Net Income? | -$33.34M | -$9.34M | $36.33M | -$70.02M | -$3.22M | -$2.19M | -$1,417 | -$8.55M | -$9.49M | -$21.68M |
| EPS? | $-0.46 | $-0.14 | $0.67 | $-2.41 | $-0.12 | $-0.09 | $-0.00 | $-0.66 | $-0.97 | $-2.59 |
| Diluted EPS? | $-0.46 | $-0.14 | $14.02 | $-2.41 | $-0.12 | $-0.09 | $-0.00 | $-0.66 | $-0.97 | $-2.59 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality